ArticleTherapeutic advances in hematology2025

Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation.

Neslihan Mandaci Ṣanli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.